Articles tagged "Kidney/pancreas transplantation"

2021 American Transplant Congress
Modification in Immunosuppression Regimens to Safely Perform Kidney Transplants Amid the Covid-19 Pandemic
L. Von Stein, O. Witkowsky, L. Samidurai, K. Flores, M. Doraiswamy, T. Pesavento, P. Singh
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: In the USA, there was a 51.1% reduction in kidney transplant (KTx) since March 2020 due to concerns for contraction of COVID-19 in transplant…
2021 American Transplant Congress
Induction Immunosuppression Efficacy in Pancreas and Kidney Transplantation in the SARS-CoV-2 Era
H. Sarumi, K. Vassar, S. Jackson, T. Pruett, R. Kandaswamy
University of Minnesota, Minneapolis, MN
*Purpose: Lymphocyte depleting induction is associated with increased risk of infection. Our institution adopted a stratified induction protocol with the intent to decrease risk for…
2021 American Transplant Congress
Simultaneous Pancreas-kidney Transplantation (spk) and, Simultaneous Deceased Donor Pancreas and Living Donor Kidney Transplantation (splk) in Diabetic Patients with End Stage Renal Disease
Y. Ko
Department of Surgery, Asan Medical Center, Seoul, Korea, Republic of
*Purpose: The purpose of this study is to compare clinical outcomes of simultaneous pancreas-kidney transplantation (SPK) and simultaneous deceased donor pancreas and living donor kidney…
2021 American Transplant Congress
Dual-Agent Induction Therapy for Pancreas Transplantation: A Single-center Experience
E. C. Liu¹, J. H. Lee¹, R. Craig-Schapiro², M. Aull², S. Sultan²
¹Pharmacy, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY, ²Kidney/Pancreas Transplant Surgery, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY
*Purpose: The optimal induction strategy in pancreas transplantation has not been elucidated. Available evidence supports use of both basiliximab and lymphocyte depleting agents. Rabbit anti-thymocyte…
2021 American Transplant Congress
Evaluation and Experience with Hepatitis C Positive to Negative PancreasTransplantation
B. K. Lindner, B. Thomas, M. Cooper, S. Yi, P. Abrams
Medstar Georgetown University Hospital, Washington, DC
*Purpose: The use of hepatitis C virus (HCV) positive organs for transplant to HCV negative recipients has been reported on and has gained popularity across…
2021 American Transplant Congress
Impact of Insulin Therapy in Pancreas Transplantation Donors on Graft Outcomes: An Analysis of the Optn/unos Database
E. Montagud-Marrahi¹, F. Ausania², Y. Fundora², A. Amor³, E. Esmatjes³, J. Ferrer², I. Revuelta¹, D. Cucchiari¹, J. Rovira⁴, M. Musquera⁵, C. Fondevila², F. Diekmann¹, P. Ventura-Aguiar¹
¹Nephrology and Kidney Transplantation Department, Hospital Clinic de Barcelona, Barcelona, Spain, ²Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic de Barcelona, Barcelona, Spain, ³Endocrinology Department, Hospital Clinic de Barcelona, Barcelona, Spain, ⁴Laboratori Experimental de Nefrologia I Trasplantament (LENIT), CRB CELLEX, Fundació Clínic, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, ⁵Urology Department, Hospital Clinic de Barcelona, Barcelona, Spain
*Purpose: Hyperglycemia requiring insulin treatment is frequent in critically ill patients and potential pancreas donors. Information on the impact of donor insulin use on pancreas…
2021 American Transplant Congress
Donor-Derived Cell-Free DNA Can Differentiate Rejection versus Other Causes of Pancreas Transplant Dysfunction
N. Ali¹, J. Miles², Z. Stewart Lewis¹
¹Transplant Institute, NYU Langone Health, New York, NY, ²CareDx, Brisbane, CA
*Purpose: Assessment and early detection of allograft injury in simultaneous pancreas and kidney (SPK) transplant recipients has clear benefits for optimizing treatment and intervention. Donor-derived…
2021 American Transplant Congress
Providing Equitable Access: Language and Literacy Levels of Kidney Transplant Center Websites
R. Olmeda Barrientos¹, C. E. Jacobson², V. S. Valbuena³, M. S. Anderson³, M. J. Englesbe³, S. A. Waits³, J. R. Santos-Parker²
¹University Of California – Riverside, School of Medicine, Riverside, CA, ²University of Michigan Medical School, Ann Arbor, MI, ³Department of Surgery, University of Michigan Health System, Ann Arbor, MI
*Purpose: Health disparities exist for access to kidney transplantation. Accessibility of patient-facing transplant center resources can contribute to these disparities. Patients interact with transplant centers…
2020 American Transplant Congress
Simultaneous Pancreas-Kidney Transplantation in Caucasian versus African American Patients: Does Recipient Ethnicity Influence Outcomes?
J. Rogers¹, A. Farney¹, G. Orlando¹, C. Jay¹, V. Gurram¹, K. Gurung¹, A. Reeves-Daniel², A. Mena-Gutierrez², N. Sakhovskaya², M. Gautreaux¹, R. Stratta¹
¹Department of Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, ²Department of Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: The influence of African American (AA) recipient ethnicity on outcomes following simultaneous pancreas-kidney transplantation (SPKT) in the modern era is uncertain.*Methods: From 11/01 to…
2020 American Transplant Congress
Direct Acting Anti-Viral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kideney Transplant Recipients
G. Gupta, I. Yakubu, D. Kumar, I. Moinuddin, L. Kamal, A. King, C. Bhati, A. Sharma, A. Cotterell, A. Khan, M. Levy, R. Sterling
Virginia Commonwealth University, Richmond, VA
*Purpose: Previous trials in kidney transplantation (KT) have described a 12-week course of direct-acting anti-viral drugs (DAA) to treat HCV transmission from infected donors to…